

Fundamental dimension Equity attribute | CHCOPeer $142.01▼-0.97% Cap $2.00BP/E 15.5x QuantScore50/100 | BHBPeer $40.46▲+2.51% Cap $678.4MP/E 12.0x QuantScore56/100 | CBNKLeader $41.29▲+0.24% Cap $672.6MP/E 12.0x QuantScore60/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
85/100 |
83/100 |
Valuation Multiples, PEG & DCF upside | 81/100 | 84/100 | 93/100 |
Health Piotroski, Altman Z, leverage & liquidity | 28/100 | 31/100 | 37/100 |
Growth Revenue / earnings growth & margins | 42/100 | 35/100 | 66/100 |
Sentiment Analyst ratings, targets & revisions | 17/100 | 44/100 | 19/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 15.5x | 12.0x | 12.0x |
Forward P/E (next FY) | 15.3x | 10.8x | 11.8x |
EV / EBITDA (TTM) | 12.9x | 8.8x | 13.7x |
Price / Sales | 5.3x | 2.9x | 2.3x |
Price / Free Cash Flow | 14.4x | 11.7x | 10.3x |
PEG ratio | 1.56 | 0.27 | 0.45 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 6 / 9 | 7 / 9 |
Altman Z-Score | -0.16 (Distress) | -0.66 (Distress) | 0.34 (Distress) |
Total debt / equity | 0.65 | 0.29 | 0.12 |
Quick ratio | 0.3x | 0.2x | 0.9x |
Interest coverage | 1.8x | 0.8x | 0.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +5.6% | +8.4% | +25.3% |
Net income growth YoY | +11.4% | -15.2% | +84.6% |
Gross margin (TTM) | 78.8% | 68.0% | 73.5% |
Operating margin (FY) | 41.5% | 19.0% | 23.3% |
FCF margin (FY) | 32.8% | 17.9% | 22.2% |
5. Trailing price performancePrice change over period |
1M return | +0.0% | +3.9% | +14.5% |
3M return | +1.7% | +3.7% | +14.3% |
6M return | +13.8% | +17.2% | +31.6% |
Year to date | +19.1% | +30.3% | +46.6% |
1Y return | +18.2% | +35.1% | +41.2% |
3Y return | +58.5% | +69.4% | +108.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $152.09 +7.1% upside | $31.20 -22.9% premium | $49.17 +19.1% upside |
Wall Street consensus target | $114.50 -19.4% · range $99.00–$130.00 | $46.00 +13.7% · range $44.00–$48.00 | $42.00 +1.7% · range $42.00–$42.00 |
Consensus stance | 0% Buy100% Hold0% Sell | 50% Buy50% Hold0% Sell | 50% Buy50% Hold0% Sell |